Cardiovascular profile and events of US adults 20-49 years with HIV: Results from the NHANES 1999-2008

AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

Volumn 25, Issue 11, 2013, Pages 1385-1391

  Gutierrez, Jose ^a   Elkind, Mitchell S V ^a   Marshall, Randolph S ^a  

^a Department of Medicine   (United States)

Author keywords

AIDS; Cardiovascular disease; Cardiovascular health; HIV; Minorities

Indexed keywords

ADULT; AFRICAN AMERICAN; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; EDUCATIONAL STATUS; ETHNIC DIFFERENCE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; HYPERTENSION; INCOME; MAJOR CLINICAL STUDY; MALE; PHYSICAL INACTIVITY; PRIORITY JOURNAL; SEX DIFFERENCE; SMOKING; SOCIAL STATUS; UNITED STATES; UNIVARIATE ANALYSIS; WAIST CIRCUMFERENCE; BLACK PERSON; CARDIOVASCULAR DISEASES; COMPLICATION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MIDDLE AGED; NUTRITION; PREVALENCE; RETROSPECTIVE STUDY; RISK; SEDENTARY LIFESTYLE; STATISTICAL MODEL; TRENDS; YOUNG ADULT;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; CARDIOVASCULAR DISEASES; FEMALE; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; HYPERTENSION; LOGISTIC MODELS; MALE; MIDDLE AGED; NUTRITION SURVEYS; ODDS RATIO; PREVALENCE; RETROSPECTIVE STUDIES; SEDENTARY LIFESTYLE; SMOKING; UNITED STATES; YOUNG ADULT;

EID: 84887468052     PISSN: 09540121     EISSN: 13600451     Source Type: Journal    
DOI: 10.1080/09540121.2013.769493     Document Type: Article

References (45)

1. Barrett, L., Fowke, K. R., & Grant, M. D. (2012). Cytomegalovirus, aging, and HIV: A perfect storm. AIDS Reviews, 14(3), 159-167. Retrieved from http://www.aidsreviews.com/resumen.asp?id=1184&indice=2012143&u=unp
2. Bozzette, S. A., Ake, C. F., Tam, H. K., Chang, S. W., & Louis, T. A. (2003). Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection. The New England Journal of Medicine, 348(8), 702-710. doi:10.1056/NEJMoa 022048348/8/702
3. Centers for Disease Control and Prevention, National Center for Health Statistics. (2000). NHANES Questionnaire (or Examination Protocol, or Laboratory Protocol), Hyattsville, MD. Retrieved from http://www.cdc.gov/nchs/nhanes/ nhanes1999-2000/nhanes99-00.htm
4. Cole, J. W., Pinto, A. N., Hebel, J. R., Buchholz, D. W., Earley, C. J., Johnson, C. J., & Kittner, S. J. (2004). Acquired immunodeficiency syndrome and the risk of stroke. Stroke, 35(1), 51-56. doi:10.1161/01.STR. 0000105393.57853.11
5. Connor, M. D., Lammie, G. A., Bell, J. E., Warlow, C. P., Simmonds, P., & Brettle, R. D. (2000). Cerebral infarction in adult AIDS patients: Observations from the Edinburgh HIV Autopsy Cohort. Stroke, 31(9), 2117-2126. doi:10.1161/01.STR.31.9.2117
6. Current cigarette smoking prevalence among working adults-United States, 2004-2010. (2011). MMWR Morbidity and Mortality Weekly Report, 60(38), 1305-1309.
7. Currier, J. S., Taylor, A., Boyd, F., Dezii, C. M., Kawabata, H., Burtcel, B., & Hodder, S. (2003). Coronary heart disease in HIV-infected individuals. Journal of Acquired Immune Deficiency Syndromes, 33(4), 506-512. doi:10.1097/00126334-200308010-00012
8. David, M. H., Hornung, R., & Fichtenbaum, C. J. (2002). Ischemic cardiovascular disease in persons with human immunodeficiency virus infection. Clinical Infectious Diseases, 34(1), 98-102. doi:10.1086/324745
9. Davis, W. W., Hartman, M. A., & Gibson, T. J. 2008. Trends in smoking prevalence by race based on the tobacco use supplement to the current population survey. Retrieved from http://www.fcsm.gov/07papers/Davis. VII-C.pdf
10. Dube, M. P., Lipshultz, S. E., Fichtenbaum, C. J., Greenberg, R., Schecter, A. D., & Fisher, S. D. (2008). Effects of HIV infection and antiretroviral therapy on the heart and vasculature. Circulation, 118(2), e36-e40. doi:10.1161/CIRCULATIONAHA.107.189625
11. Eugenin, E. A., Morgello, S., Klotman, M. E., Mosoian, A., Lento, P. A., Berman, J. W., & Schecter, A. D. (2008). Human immunodeficiency virus (HIV) infects human arterial smooth muscle cells in vivo and in vitro: Implications for the pathogenesis of HIV mediated vascular disease. The American Journal of Pathology, 172(4), 1100-1111. doi:10.2353/ajpath. 2008.070457
12. Fisher, S. D., Easley, K. A., Orav, E. J., Colan, S. D., Kaplan, S., Starc, T. J., & Lipshultz, S. E. (2005). Mild dilated cardiomyopathy and increased left ventricular mass predict mortality: The prospective P2C2 HIV Multicenter Study. American Heart Journal, 150(3), 439-447. doi:10.1016/j.ahj. 2005.06.012
13. Friis-Moller, N., Sabin, C. A., Weber, R., d'Arminio Monforte, A., El-Sadr, W. M., Reiss, P., & Lundgren, J. D. (2003). Combination antiretroviral therapy and the risk of myocardial infarction. The New England Journal of Medicine, 349(21), 1993-2003. doi:10.1056/NEJMoa030218
14. Friis-Moller, N., Weber, R., Reiss, P., Thiebaut, R., Kirk, O., d'Arminio Monforte, A., & Lipshultz, S. E. (2003). Cardiovascular disease risk factors in HIV patients-Association with antiretroviral therapy. Results from the DAD study. AIDS, 17(8), 1179-1193. doi:10.1097/01.aids.0000060358.78202.c1
15. Grinspoon, S., & Carr, A. (2005). Cardiovascular risk and body-fat abnormalities in HIV-infected adults. New England Journal of Medicine, 352(1), 48-62. doi:10.1056/NEJMra041811
16. Grinspoon, S. K., Grunfeld, C., Kotler, D. P., Currier, J. S., Lundgren, J. D., Dube, M. P., & Eckel, R. H. (2008). State of the science conference: Initiative to decrease cardiovascular risk and increase quality of care for patients living with HIV/AIDS: Executive summary. Circulation, 118(2), 198-210. doi:CIRCULATIONAHA. 107.189622
17. Gutierrez, J., Glenn, M., Isaacson, R., Marr, D., Mash, D., & Petito, C. (2012). Thinning of the arterial media layer as a possible preclinical stage in HIV vasculopathy: A pilot study. Stroke, 43(4), 1156-1158. doi:10.1161/STROKEAHA.111.643387
18. Hengge, U. R., Reimann, G., Schafer, A., & Goos, M. (2003). HIV-positive men differ in immunologic but not catecholamine response to an acute psychological stressor. Psychoneuroendocrinology, 28(5), 643-656. doi:10.1016/S0306-4530(02)00048-3
19. HIV surveillance-United States, 1981-2008. (2011). MMWR Morbidity and Mortality Weekly Report, 60(21), 689-693.
20. Hoffmann, M., Berger, J. R., Nath, A., & Rayens, M. (2000). Cerebrovascular disease in young, HIV-infected, black Africans in the KwaZulu Natal province of South Africa. Journal of Neurovirology, 6(3), 229-236. doi:10.3109/13550280009015825
21. Hooshyar, D., Hanson, D. L., Wolfe, M., Selik, R. M., Buskin, S. E., & McNaghten, A. D. (2007). Trends in perimortal conditions and mortality rates among HIV infected patients. AIDS, 21(15), 2093-2100. doi:10.1097/QAD. 0b013e3282e9a664
22. Hsue, P. Y., Deeks, S. G., & Hunt, P. W. (2012). Immunologic basis of cardiovascular disease in HIV infected adults. Journal of Infectious Diseases, 205(Suppl. 3), S375-S382. doi:10.1093/infdis/jis200
23. Hsue, P. Y., Hunt, P. W., Sinclair, E., Bredt, B., Franklin, A., Killian, M., & Deeks, S. G. (2006). Increased carotid intima-media thickness in HIV patients is associated with increased cytomegalovirus-specific Tcell responses. AIDS, 20(18), 2275-2283. doi:10.1097/QAD.0b013e3280108704
24. Klein, D., Hurley, L. B., Quesenberry, C. P., Jr., & Sidney, S. (2002). Do protease inhibitors increase the risk for coronary heart disease in patients with HIV-1 infection? JAIDS Journal of Acquired Immune Deficiency Syndromes, 30(5), 471-477. doi:10.1097/00126334-200208150-00002
25. Lai, S., Lima, J. A., Lai, H., Vlahov, D., Celentano, D., Tong, W., & Fishman, E. K. (2005). Human immunodeficiency virus 1 infection, cocaine, and coronary calcification. Archives of Internal Medicine, 165(6), 690-695. doi:10.1001/archinte.165.6.690
26. Lewis, W. (2000). Cardiomyopathy in AIDS: A pathophysiological perspective. Progress in Cardiovascular Diseases, 43(2), 151-170. doi:10.1053/pcad.2000.9031
27. Lewis, C. E., McTigue, K. M., Burke, L. E., Poirier, P., Eckel, R. H., Howard, B. V., & Pi-Sunyer, F. X. (2009). Mortality, health outcomes, and body mass index in the overweight range: A science advisory from the American Heart Association. Circulation, 119(25), 3263-3271. doi:10.1161/CIRCULATIONAHA. 109. 192574
28. Lipshultz, S. E., Easley, K. A., Orav, E. J., Kaplan, S., Starc, T. J., Bricker, J. T., et al. (2000). Cardiac dysfunction and mortality in HIV-infected children: The prospective P2C2 HIV multicenter study. Pediatric pulmonary and cardiac complications of vertically transmitted HIV infection (P2C2 HIV) study group. Circulation, 102(13), 1542-1548. doi:10.1161/01.CIR .102.13.1542
29. McQuillan, G. M., & Kruszon-Moran, D. (2008). HIV infection in the United States household population aged 18-49 years: Results from 1999-2006. NCHS Data Brief, 4, 1-8. Retrieved from http://www.ncbi. nlm.nih.gov/pubmed/ 19389318
30. NHANES. (2010). Analytic note regarding 2007-2010 survey design changes and combining data across other survey cycles. Retrieved from http://www.cdc.gov/nchs/data/nhanes/analyticnote-2007-2010.pdf
31. Neumann, T., Woiwoid, T., Neumann, A., Miller, M., Ross, B., Volbracht, L., & Erbel, R. (2003). Cardiovascular risk factors and probability for cardiovascular events in HIV-infected patients: Part I. Differences due to the acquisition of HIV-infection. European Journal of Medical Research, 8(6), 229-235. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/12911871
32. NHANES analytic guideliness, Centers for Disease Control and Prevention (CDC), & National Center for Health Statistics (NCHS). (2004). Hyattsville, MD. Retrieved from http://www.cdc.gov/nchs/data/nhanes/nhanes-general- guidelines-june-04.pdf
33. Palella, F. J., Jr., Baker, R. K., Moorman, A. C., Chmiel, J. S., Wood, K. C., Brooks, J. T., & Holmberg, S. D. (2006). Mortality in the highly active antiretroviral therapy era: Changing causes of death and disease in the HIV outpatient study. Journal of Acquired Immune Deficiency Syndromes, 43(1), 27-34. doi:10.1097/01.qai.0000233310.90484.16
34. Palella, F. J., Jr., Delaney, K. M., Moorman, A. C., Loveless, M. O., Fuhrer, J., Satten, G. A., & Holmberg, S. D. (1998). Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. New England Journal of Medicine, 338(13), 853-860. doi:10.1056/NEJM199803263381301
35. Petoumenos, K., Worm, S., Reiss, P., de Wit, S., d'Arminio Monforte, A., Sabin, C., & Law, M. (2011). Rates of cardiovascular disease following smoking cessation in patients with HIV infection: Results from the D:A:D study. HIV Medicine, 12(7), 412-421. doi:10.1111/j.1468-1293.2010.00901.x
36. Roger, V. L., Go, A. S., Lloyd-Jones, D. M., Adams, R. J., Berry, J. D., Brown, T. M., & Wylie-Rosett, J. (2011). Heart disease and stroke statistics-2011 update: A report from the American Heart Association. Circulation, 123(4), 18-209. doi:10.1161/CIR.0b013e 3182009701
37. Saves, M., Chene, G., Ducimetiere, P., Leport, C., Le Moal, G., Amouyel, P., & Raffi, F. (2003). Risk factors for coronary heart disease in patients treated for human immunodeficiency virus infection compared with the general population. Clinical Infectious Diseases, 37(2), 292-298. doi:10.1086/375844
38. Siddiqi, Z., Tiro, J. A., & Shuval, K. (2011). Understanding impediments and enablers to physical activity among African American adults: A systematic review of qualitative studies. Health Education Research, 26(6), 1010-1024. doi:10.1093/her/cyr068
39. Smith, C. J., Scott, S. M., & Wagner, B. M. (1998). The necessary role of the autopsy in cardiovascular epidemiology. Human Pathology, 29(12), 1469-1479. doi:10.1016/S0046-8177(98)90018-1
40. Stein, J. H., Klein, M. A., Bellehumeur, J. L., McBride, P. E., Wiebe, D. A., Otvos, J. D., & Sosman, J. M. (2001). Use of human immunodeficiency virus-1 protease inhibitors is associated with atherogenic lipoprotein changes and endothelial dysfunction. Circulation, 104(3), 257-262. doi:10.1161/01.CIR. 104.3.257
41. Triant, V. A., Lee, H., Hadigan, C., & Grinspoon, S. K. (2007). Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. Journal of Clinical Endocrinology and Metabolism, 92(7), 2506-2512. doi:10.1210/jc.2006-2190
42. US Census Bureau, Poverty definitions. (2012). Retrieved from http://www.census.gov/hhes/www/poverty/methods/definitions.html#ratio of income to poverty
43. Voelker, R. (2011). Stroke increase reported in HIV patients. JAMA: The Journal of the American Medical Association, 305(6), 552. doi:10.1001/jama.2011. 101
44. When and How to Construct Weights When Combining Survey Cycles. CDC, NCHS. NHANES Questionnaire. (2011). Hyattsville, MD. Retrieved from http://www.cdc.gov/nchs/tutorials/NHANES/SurveyDesign/Weighting/Task2.htm
45. Wolf, K., Tsakiris, D. A., Weber, R., Erb, P., & Battegay, M. (2002). Antiretroviral therapy reduces markers of endothelial and coagulation activation in patients infected with human immunodeficiency virus type 1. The Journal of Infectious Diseases, 185(4), 456-462. doi:10.1086/338572